Drug Trial Radar · NCT00170989
Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
Last checked: Nov 20, 2026Latest source record: Nov 8, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,714
Actual
Start
Sep 2004
Primary completion
Jul 2005
Study completion Jul 2005
Sponsor
- Lead sponsor
- NovartisNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Sep 15, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
Summary
As written by the sponsor on the registry.
This study will test the effectiveness and safety of a combination treatment in patients whose blood pressure is not controlled with a single medication.
Conditions
- Hypertension
Interventions
valsartan plus hydrochlorothiazideDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in diastolic blood pressure from baseline after 8 weeks
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
Site not named
Investigative Centers, Germany
Novartis Pharmaceuticals
Basel, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.